Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sowmya Sharma

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Digestive Diseases and Sciences|August 4, 2023
Superior Efficacy of Infliximab Versus Adalimumab for First-Line Treatment of Crohn's Perianal FistulaeLaura Maas, Ruiyi Gao, Vivy Cusumano, et al.
Clinical and Experimental Gastroenterology|December 13, 2023
PSMA-Targeted PET Radiotracer [<sup>18</sup>F]DCFPyL as an Imaging Biomarker in Inflammatory Bowel DiseaseMohamed Saleh Ismail, Diane E Peters, Steven P Rowe, et al.
Experimental Hematology & Oncology|January 9, 2023
Alpha-B-Crystallin overexpression is sufficient to promote tumorigenesis and metastasis in miceBehnam Rashidieh, Amanda Louise Bain, Simon Manuel Tria, et al.
Plos One|December 31, 2024
Primary healthcare provider-perceived barriers to implementing an evidence-based pathway for undifferentiated lower gastrointestinal tract symptoms: A qualitative inquirySowmya Sharma, Michael J Stewart, Holly Mathias, et al.
Scientific Reports|May 6, 2023
Generalising uncertainty improves accuracy and safety of deep learning analytics applied to oncologySamual MacDonald, Helena Foley, Melvyn Yap, et al.
BMC Cancer|May 26, 2026
Whole genome sequencing in oesophageal adenocarcinoma unmasks potential precision therapiesSowmya Sharma, Ho Yi Wong, Rebecca L Johnston, et al.
Frontiers in Immunology|November 15, 2023
The oesophageal adenocarcinoma tumour immune microenvironment dictates outcomes with different modalities of neoadjuvant therapy - results from the AGITG DOCTOR trial and the cancer evolution biobankJames M Lonie, Sandra Brosda, Vanessa F Bonazzi, et al.
Medicina (Kaunas, Lithuania)|August 26, 2023
Antibody Kinetics after Three Doses of SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel DiseaseEvangelos Tsipotis, Ankith Maremanda, Laura Bowles Zeiser, et al.
Inflammatory Bowel Diseases|September 19, 2025
Incidence of Anti-Drug Antibody Development in Older Adults with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha Inhibitors: A Large Multicenter Cohort StudySpencer Frost, Chetan Ambastha, Devin Patel, et al.
JTO Clinical and Research Reports|September 23, 2022
Prospective Optimization of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Lymph Node Assessment for Lung Cancer: Three Needle Agitations Are Noninferior to 10 Agitations for Adequate Tumor Cell and DNA YieldDavid Fielding, Andrew J Dalley, Mahendra Singh, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Digestive Diseases and Sciences|August 4, 2023
Superior Efficacy of Infliximab Versus Adalimumab for First-Line Treatment of Crohn's Perianal FistulaeLaura Maas, Ruiyi Gao, Vivy Cusumano, et al.
Clinical and Experimental Gastroenterology|December 13, 2023
PSMA-Targeted PET Radiotracer [<sup>18</sup>F]DCFPyL as an Imaging Biomarker in Inflammatory Bowel DiseaseMohamed Saleh Ismail, Diane E Peters, Steven P Rowe, et al.
Experimental Hematology & Oncology|January 9, 2023
Alpha-B-Crystallin overexpression is sufficient to promote tumorigenesis and metastasis in miceBehnam Rashidieh, Amanda Louise Bain, Simon Manuel Tria, et al.
Plos One|December 31, 2024
Primary healthcare provider-perceived barriers to implementing an evidence-based pathway for undifferentiated lower gastrointestinal tract symptoms: A qualitative inquirySowmya Sharma, Michael J Stewart, Holly Mathias, et al.
Scientific Reports|May 6, 2023
Generalising uncertainty improves accuracy and safety of deep learning analytics applied to oncologySamual MacDonald, Helena Foley, Melvyn Yap, et al.
BMC Cancer|May 26, 2026
Whole genome sequencing in oesophageal adenocarcinoma unmasks potential precision therapiesSowmya Sharma, Ho Yi Wong, Rebecca L Johnston, et al.
Frontiers in Immunology|November 15, 2023
The oesophageal adenocarcinoma tumour immune microenvironment dictates outcomes with different modalities of neoadjuvant therapy - results from the AGITG DOCTOR trial and the cancer evolution biobankJames M Lonie, Sandra Brosda, Vanessa F Bonazzi, et al.
Medicina (Kaunas, Lithuania)|August 26, 2023
Antibody Kinetics after Three Doses of SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel DiseaseEvangelos Tsipotis, Ankith Maremanda, Laura Bowles Zeiser, et al.
Inflammatory Bowel Diseases|September 19, 2025
Incidence of Anti-Drug Antibody Development in Older Adults with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha Inhibitors: A Large Multicenter Cohort StudySpencer Frost, Chetan Ambastha, Devin Patel, et al.
JTO Clinical and Research Reports|September 23, 2022
Prospective Optimization of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Lymph Node Assessment for Lung Cancer: Three Needle Agitations Are Noninferior to 10 Agitations for Adequate Tumor Cell and DNA YieldDavid Fielding, Andrew J Dalley, Mahendra Singh, et al.
Pageof 3